Abbott and DexCom settle glucose monitor patent disputes
Portfolio Pulse from
Abbott Laboratories and DexCom have reached a settlement to resolve all patent disputes concerning their continuous glucose monitoring devices.
December 23, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott Laboratories has settled all patent disputes with DexCom regarding continuous glucose monitoring devices, potentially reducing legal uncertainties.
The settlement removes legal uncertainties and potential costs associated with ongoing litigation, which is positive for Abbott's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
DexCom has settled all patent disputes with Abbott Laboratories concerning continuous glucose monitoring devices, potentially reducing legal uncertainties.
The settlement removes legal uncertainties and potential costs associated with ongoing litigation, which is positive for DexCom's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80